NCT01672645View on ClinicalTrials.gov

A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.

PHASE1CompletedINTERVENTIONAL
Enrollment

277

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
SmokingVaccines
Interventions
BIOLOGICAL

NIC7-001

Intramuscular, multiple dose

BIOLOGICAL

NIC7-003

Intramuscular, multiple dose

BIOLOGICAL

Saline

Saline (0.9% sodium chloride)

Trial Locations (3)

M5V 2T3

INC Research Toronto Inc., Toronto

H2Y 1S1

Diex Research Montreal, Inc., Montreal

J1H 1Z1

Diex Research Sherbrooke Inc., Sherbrooke

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01672645 - A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers. | Biotech Hunter | Biotech Hunter